These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7701630)

  • 1. [Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
    Nielsen JC; Nicholson K; Pitzner-Jørgensen BL; Undén M
    Ugeskr Laeger; 1995 Feb; 157(6):724-7. PubMed ID: 7701630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ecstasy].
    Trkulja V; Lacković Z
    Lijec Vjesn; 1997; 119(5-6):158-66. PubMed ID: 9379824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
    Bango J; Fadón P; Mata F; Rubio G; Santo-Domingo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(4):260-3. PubMed ID: 9807860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 10. Methodological problems with ecstasy and the SCL-90.
    Cole JC; Sumnall HR; Wagstaff GF
    Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
    [No Abstract]   [Full Text] [Related]  

  • 11. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG; Sorrentino R; Lukas SE; Price BH
    Harv Rev Psychiatry; 2002; 10(4):212-20. PubMed ID: 12119307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ecstasy--cool dope with long-lasting effects?].
    Liberg JP; Hovda KE; Nordby G; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4384-7. PubMed ID: 9889612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories.
    Skrinska VA; Gock SB
    Clin Lab Sci; 2005; 18(2):119-23. PubMed ID: 15916245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA; Rosner MH
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users.
    Stuerenburg HJ; Petersen K; Bäumer T; Rosenkranz M; Buhmann C; Thomasius R
    Neuro Endocrinol Lett; 2002 Jun; 23(3):259-61. PubMed ID: 12080289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy (MDMA) and oral health.
    Brand HS; Dun SN; Nieuw Amerongen AV
    Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.